Presentation of a comparison between digital and glass slide histology from screening biopsies in the Phase 3 NATiV3 studyPresentation of digital ...

The Phase 1b trial will evaluate the safety and tolerability of cemsidomide, an IKZF1/3 degrader, and dexamethasone in combination with elranatamab as a second line or later therapy for patients with ...

In her lawsuit, Melissa Tempel claimed her firing was in retaliation for comments she made on the social media platform ...

May Faculty and Staff GrantsRestrictedCasey Myers, Ritchie School of Engineering & Computer ScienceFunder: RestrictedAbstract ...

The Company announced on May 1, 2025 it had completed Phase One which included driving a 12 foot x12 foot adit capable of ...

In-the-wild testing of police facial recognition systems has failed to generate clear evidence of the technology’s benefits, ...

Strategic Alliances – IQSTEL and Cycurion (Nasdaq: CYCU) executed a $1M stock exchange and dividend distribution, with IQSTEL planning to distribute $500,000 in Cycurion Nasdaq shares to its ...

Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event rates to placebo in Phase 3 ICONIC-ADVANCE studies Icotrokinra also showed ...

Discover how integrating artificial intelligence with biophysical methods enables the identification of novel BRPF1b ...

Invested in Stalicla SA, confirming commitment to advancing innovative treatments for CNS disorders ...

During the incident, a sudden rush of approximately 800,000 metric tons of wet material entered the mine and traveled rapidly to multiple mine levels ... To prioritize the search, mining operations in ...

Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that ...